Page last updated: 2024-09-05

paromomycin and Dientamoeba fragilis Infection

paromomycin has been researched along with Dientamoeba fragilis Infection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Abellana, R; Burgaña, A; García-Puig, R; Gonçalves, AQ; Hernández, CG; Kazan, R; Padilla, E; Pérez Ortiz, AM; Pérez, J; Perez-Porcuna, TM; Ramos, CC; Rivero, MM; Yordanov, SZ1
Carlet, R; Clemente, L; Fontana, F; Pasut, M; Ruscio, M1
Boga Ribeiro, JA; Fernández-Suarez, J; Gonzalez-Sotorrios, N; Menéndez, C; Rodríguez-Guardado, A; Rodríguez-Pérez, M; Vázquez, F1
Dediste, A; Mouchet, F; Souayah, H; van Gool, T; Vandenberg, O1
Wolfe, MS1

Reviews

1 review(s) available for paromomycin and Dientamoeba fragilis Infection

ArticleYear
The treatment of intestinal protozoan infections.
    The Medical clinics of North America, 1982, Volume: 66, Issue:3

    Topics: Amebicides; Antimalarials; Antiprotozoal Agents; Balantidiasis; Chloroquine; Coccidiosis; Dientamoebiasis; Drug Combinations; Dysentery, Amebic; Emetine; Furans; Furazolidone; Giardiasis; Humans; Intestinal Diseases, Parasitic; Iodoquinol; Liver Abscess, Amebic; Metronidazole; Paromomycin; Quinacrine; Sulfamethoxazole; Tetracycline; Tinidazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1982

Other Studies

4 other study(ies) available for paromomycin and Dientamoeba fragilis Infection

ArticleYear
Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment.
    International journal for parasitology. Drugs and drug resistance, 2019, Volume: 11

    Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Dientamoeba; Dientamoebiasis; Feces; Female; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Paromomycin; Spain; Treatment Outcome; Young Adult

2019
Dientamoeba fragilis in the North-East of Italy: Prevalence study and treatment.
    Parasitology international, 2021, Volume: 80

    Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Child, Preschool; Cross-Sectional Studies; Dientamoeba; Dientamoebiasis; Female; Humans; Infant; Italy; Male; Metronidazole; Middle Aged; Paromomycin; Prevalence; Young Adult

2021
Epidemiological and clinical characteristics of Dientamoeba fragilis infection.
    Enfermedades infecciosas y microbiologia clinica (English ed.), 2019, Volume: 37, Issue:5

    Topics: Adult; Antiprotozoal Agents; Dientamoebiasis; Female; Humans; Male; Metronidazole; Middle Aged; Paromomycin; Retrospective Studies; Young Adult

2019
Treatment of Dientamoeba fragilis infection with paromomycin.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:1

    Topics: Adolescent; Amebicides; Animals; Child; Child, Preschool; Dientamoeba; Dientamoebiasis; Female; Gastrointestinal Diseases; Humans; Infant; Male; Paromomycin

2007